Gland Pharma slides after Q1 PAT slumps 26% YoY to Rs 144 cr

Gland Pharma dropped 3.37% to Rs 2038.30 after the company's consolidated net profit declined 25.94% to Rs 143.76 crore in Q1 FY25 as compared with Rs 194.10 crore in Q1 FY24.